BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21931056)

  • 1. High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Nakajima S; Watanabe H; Tohyama M; Sugita K; Iijima M; Hashimoto K; Tokura Y; Nishimura Y; Doi H; Tanioka M; Miyachi Y; Kabashima K
    Arch Dermatol; 2011 Sep; 147(9):1110-2. PubMed ID: 21931056
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Fujita Y; Yoshioka N; Abe R; Murata J; Hoshina D; Mae H; Shimizu H
    J Am Acad Dermatol; 2011 Jul; 65(1):65-8. PubMed ID: 21507517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J
    Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
    [No Abstract]   [Full Text] [Related]  

  • 5. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fritsch P
    Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 7. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Roujeau JC
    Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
    Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
    Watanabe H; Iijima M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():336-40. PubMed ID: 18072345
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome.
    Gaultier F; Ejeil AL; Igondjo-Tchen S; Dohan D; Dridi SM; Maman L; Wierzba CB; Stania D; Pellat B; Lafont A; Godeau G; Gogly B
    Arch Dermatol Res; 2004 Oct; 296(5):220-5. PubMed ID: 15449075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

  • 15. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyell's disease, the Stevens-Johnson Syndrome, and exfoliative dermatitis.
    Ostler HB; Conant MA; Groundwater J
    Trans Am Acad Ophthalmol Otolaryngol; 1970; 74(6):1254-65. PubMed ID: 4250164
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids.
    Shammas MC; Lai EC; Sarkar JS; Yang J; Starr CE; Sippel KC
    Am J Ophthalmol; 2010 Feb; 149(2):203-213.e2. PubMed ID: 20005508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interrelation of erythema multiforme exudativum, the Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome)].
    Anton'eva AA; Shevarova VN
    Vestn Dermatol Venerol; 1981 Jul; (7):29-30. PubMed ID: 7293469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Erythema multiforme exudativum, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's syndrome) and their interrelationship].
    Kalamkarian AA; Samsonov VA
    Vestn Dermatol Venerol; 1980 Mar; (3):36-42. PubMed ID: 6990649
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases.
    Lee HY; Tey HL; Pang SM; Thirumoorthy T
    Lupus; 2011 May; 20(6):647-52. PubMed ID: 21148602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.